問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Thoracic Medicine

Division of Hematology & Oncology

更新時間:2023-09-19

黃宗禎
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

5Cases

2025-05-01 - 2030-04-30

Phase III

Active
A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • Condition/Disease

    Extensive Stage Small Cell Lung Cancer (ES-SCLC)

  • Test Drug

    Injectable frozen powder

Participate Sites
9Sites

Recruiting9Sites

2025-12-01 - 2032-01-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

2024-05-21 - 2029-02-22

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Not yet recruiting1Sites

Recruiting7Sites

2022-11-30 - 2027-10-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting9Sites

2022-10-05 - 2024-02-12

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting9Sites